We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IAT) in patients with ischemic stroke on non-vitamin K antagonist oral anticoagulants (NOACs, last intake <48 hours) in comparison with patients (1) taking vitamin K antagonists (VKAs) or (2) without previous anticoagulation (no-OAC)
Background: The emergency management of patients with acute ischemic stroke (IS) using oral anticoag...
Background and Purpose—Prospective data on the safety of endovascular thrombectomy in acute stroke p...
Anticoagulant use, such as heparin, is usually contraindicated in acute stroke patients. We present ...
We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IAT) in patien...
BACKGROUND We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IA...
BACKGROUND: We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IA...
BackgroundNon-vitamin K antagonist oral anticoagulants (NOAC) are equally or potentially superior in...
The aim was to evaluate, in patients with atrial fibrillation (AF) and acute ischemic stroke, the as...
BACKGROUND:Non-vitamin K antagonist oral anticoagulants (NOAC) are equally or potentially superior i...
This study represents the largest clinical experience of stroke thrombolysis in patients receiving N...
Vitamin K antagonist (VKA) frequently fails to prevent cerebral infarction, with 30 % of VKA-treated...
Purpose: There are various patterns in determining the choice of the first-line antithrombotic agent...
The primary aim of thrombolysis in acute ischemic stroke is recanalization of an occluded intracrani...
Background Intravenous thrombolysis (IVT) is an effective stroke therapy that remains underused. Cur...
IMPORTANCE International guidelines recommend avoiding intravenous thrombolysis (IVT) in patients wi...
Background: The emergency management of patients with acute ischemic stroke (IS) using oral anticoag...
Background and Purpose—Prospective data on the safety of endovascular thrombectomy in acute stroke p...
Anticoagulant use, such as heparin, is usually contraindicated in acute stroke patients. We present ...
We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IAT) in patien...
BACKGROUND We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IA...
BACKGROUND: We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IA...
BackgroundNon-vitamin K antagonist oral anticoagulants (NOAC) are equally or potentially superior in...
The aim was to evaluate, in patients with atrial fibrillation (AF) and acute ischemic stroke, the as...
BACKGROUND:Non-vitamin K antagonist oral anticoagulants (NOAC) are equally or potentially superior i...
This study represents the largest clinical experience of stroke thrombolysis in patients receiving N...
Vitamin K antagonist (VKA) frequently fails to prevent cerebral infarction, with 30 % of VKA-treated...
Purpose: There are various patterns in determining the choice of the first-line antithrombotic agent...
The primary aim of thrombolysis in acute ischemic stroke is recanalization of an occluded intracrani...
Background Intravenous thrombolysis (IVT) is an effective stroke therapy that remains underused. Cur...
IMPORTANCE International guidelines recommend avoiding intravenous thrombolysis (IVT) in patients wi...
Background: The emergency management of patients with acute ischemic stroke (IS) using oral anticoag...
Background and Purpose—Prospective data on the safety of endovascular thrombectomy in acute stroke p...
Anticoagulant use, such as heparin, is usually contraindicated in acute stroke patients. We present ...